Medigus (NASDAQ:MDGS – Get Free Report) and DarioHealth (NASDAQ:DRIO – Get Free Report) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations. Volatility & Risk Medigus has a beta of […]
DarioHealth (NASDAQ:DRIO – Get Free Report) announced its earnings results on Thursday. The company reported ($0.58) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.52) by ($0.06), reports. DarioHealth had a negative net margin of 120.19% and a negative return on equity of 39.85%. The business had revenue of $6.15 million during […]
Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers.